Stock Rating Upgrade
The Value Trend Rating for Teva Pharmaceutical Industries L (NYSE: TEVA) improved of late from C to B reflecting improving fundamentals and high Appreciation Potential. Details supporting this higher rating are included in our next report.
Recent Price Action
Teva Pharmaceutical Industries L (NYSE: TEVA) stock closed at $19.31 on 10/17/25 after a modest decline of -1.6%. However, below average trading volume at 76% of normal accompanied the decline. The stock has declined -3.6% during the last week but has been strong relative to the market over the last nine months.
Current PriceTarget Research Rating
Teva Pharmaceutical Industries L has a current Value Trend Rating of B (Positive). This VT Rating improved in recent days from C previously. This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Teva Pharmaceutical Industries L has a neutral Power Rating of 57 and a slightly positive Appreciation Score of 68, triggering the Positive Value Trend Rating.
Be the first to comment